Guangzhou Baiy | 600332 - Operating Expenses

Stock Price
23.03
Daily Change
-0.13 -0.56%
Monthly
-7.81%
Yearly
-8.76%
Q2 Forecast
22.49

Guangzhou Baiy reported CNY16.64B in Operating Expenses for its fiscal quarter ending in December of 2025.





Operating Expenses Change Date
Aspen Pharmacare ZAR 13.32B 5.36B Dec/2025
Cipla INR 60.98B 1.06B Dec/2025
Dr.Reddys Laboratories INR 73.6B 1.79B Dec/2025
Jiangsu Hengrui CNY 6.12B 180.16M Dec/2025
Kalbe Farma IDR 8.06T 883.47B Sep/2025
Richter Gedeon HUF 151.11B 20.72B Sep/2025
Sh Fosun Pharma CNY 11.3B 2.18B Dec/2025
Sh Pharmaceutical CNY 66.41B 5.25B Dec/2025
Sun Pharmaceuticals INR 111.11B 6.97B Sep/2025
Teva Pharmaceutical Industries USD 4.22B 812M Dec/2025